A newly published study showed that patients with relapsing multiple sclerosis (RMS) who started ocrelizumab (Ocrevus; ...

Clene has filed an NDA seeking accelerated approval of CNM-Au8 for ALS, following 2 missed primary trial endpoints and years ...

The NeurologyLive ® Editorial Advisory Board consists of physicians, clinicians, and researchers across the breadth of neurology who help to define the trends and drive the conversations in their ...

This week on NeurologyLive, there are a number of hot topics that we will be post ...

Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions ...

Intravenousocrelizumab (Ocrevus; Genentech) demonstrated noninferiority to oral fingolimod (Gilenya; Novartis) for ...

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Nicholas J. Maragakis, MD; and Jinsy Andrews, MD, MSc, FAAN, FANA. [LISTEN TIME: 23 minutes] ...

Leonard Dragone, MD, PhD, Disease Area Leader at Johnson & Johnson, discusses how nipocalimab is being incorporated into generalized MG care, what long-term data show, and where J&J sees the therapy’s ...

The FDA has approved a once-daily autoinjector for zilucoplan (ZILBRYSQ), giving adults with generalized myasthenia gravis (gMG) a second self-administered delivery option for the ...

This episode, "Follow-Up Care and the Caregiver's Role in Managing Agitation," features the panel closing the series with a ...

Three-year extension data from the phase 3 IB1001-301 trial show levacetylleucine slowed disease progression in both adults and children with Niemann-Pick disease type C.

Welcome to NeurologyLive® 's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive 's widespread coverage in ...